NLRP3 and COVID-19: SARS-CoV-2 nucleocapsid (N) promotes NOD-like receptor protein 3 (NLRP3) inflammasome activation to induce hyperinflammation and severe symptoms of coronavirus disease-19 (COVID-19) by promoting the binding of NLRP3 with ASC and facilitating NLRP3 inflammasome assembly [14].